About Cadence Neuroscience
Cadence Neuroscience is a company based in Redmond (United States) founded in 2016.. Cadence Neuroscience has raised $41.03 million across 3 funding rounds from investors including Mayo Clinic, LivaNova and Epilepsy Foundation. Cadence Neuroscience offers products and services including BTS Device. Cadence Neuroscience operates in a competitive market with competitors including NeuroPace, Engage Therapeutics, Cyberonics, CerboMed and NightWatch, among others.
- Headquarter Redmond, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Cadence Neuroscience, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.03 M (USD)
in 3 rounds
-
Latest Funding Round
$26.03 M (USD), Series B
Feb 28, 2023
-
Investors
Mayo Clinic
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cadence Neuroscience
Cadence Neuroscience offers a comprehensive portfolio of products and services, including BTS Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers targeted electrical stimulation for epilepsy treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Cadence Neuroscience
Cadence Neuroscience has successfully raised a total of $41.03M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $26.03 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $26.0M
- First Round First Round
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series B - Cadence Neuroscience | Valuation | Angelini Lumira Biosciences Fund | |
| Oct, 2019 | Amount | Grant - Cadence Neuroscience | Valuation |
investors |
|
| Oct, 2019 | Amount | Series A - Cadence Neuroscience | Valuation | JAZZ Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cadence Neuroscience
Cadence Neuroscience has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, LivaNova and Epilepsy Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Angelini Ventures is focused on investing in BioTech and Digital Health.
|
Founded Year | Domain | Location | |
|
Tech & Life Science focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cadence Neuroscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cadence Neuroscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cadence Neuroscience Comparisons
Competitors of Cadence Neuroscience
Cadence Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroPace, Engage Therapeutics, Cyberonics, CerboMed and NightWatch, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable neurostimulation systems for epilepsy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures
|
|
| domain | founded_year | HQ Location |
Vagus nerve stimulation therapy is developed for epilepsy and depression.
|
|
| domain | founded_year | HQ Location |
Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders.
|
|
| domain | founded_year | HQ Location |
Wearable armbands for detecting epileptic seizures during sleep are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cadence Neuroscience
Frequently Asked Questions about Cadence Neuroscience
When was Cadence Neuroscience founded?
Cadence Neuroscience was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is Cadence Neuroscience located?
Cadence Neuroscience is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Who is the current CEO of Cadence Neuroscience?
Kent Leyde is the current CEO of Cadence Neuroscience.
Is Cadence Neuroscience a funded company?
Cadence Neuroscience is a funded company, having raised a total of $41.03M across 3 funding rounds to date.
What does Cadence Neuroscience do?
Cadence Neuroscience was founded in 2016 in Redmond, United States, within the medical devices sector. Therapies targeting neurological disorders, including epilepsy and central pain, are being developed by the company. Focus is placed on an implantable device designed for epilepsy treatment. Operations center on advancing device-based solutions for these conditions, with leadership provided by CEO Kent Leyde.
Who are the top competitors of Cadence Neuroscience?
Cadence Neuroscience's top competitors include NeuroPace, Engage Therapeutics and Cyberonics.
What products or services does Cadence Neuroscience offer?
Cadence Neuroscience offers BTS Device.
Who are Cadence Neuroscience's investors?
Cadence Neuroscience has 9 investors. Key investors include Mayo Clinic, LivaNova, Epilepsy Foundation, F-Prime Capital, and Angelini Ventures.